Detalhe da pesquisa
1.
Association between maternal dupilumab exposure and pregnancy outcomes in patients with moderate-to-severe atopic dermatitis: A nationwide retrospective cohort study.
J Eur Acad Dermatol Venereol;
2024 Jan 29.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38284131
2.
"Your Skin Tells You" Campaign for Keratinocyte Cancers: When Individuals' Selection Makes the Difference.
Dermatology;
239(3): 387-392, 2023.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36754039
3.
Bath-PUVA still represents a valuable treatment option for the subsets of psoriatic patients who are not eligible to or rejecting systemic treatments and are not responsive to NB-UVB phototherapy.
Photodermatol Photoimmunol Photomed;
39(4): 351-356, 2023 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36398948
4.
A Short Cycle of Narrow-Band UVB Phototherapy in the Early Phase of Dupilumab Therapy Can Provide a Quicker Improvement of Severe Atopic Dermatitis.
Dermatology;
237(3): 407-415, 2021.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33401279
5.
A Critical Reappraisal of Off-Label Use of Photodynamic Therapy for the Treatment of Non-Neoplastic Skin Conditions.
Dermatology;
237(2): 262-276, 2021.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32554971
6.
Clinical outcomes and management of JAK inhibitor-associated acne in patients with moderate-to-severe atopic dermatitis undergoing upadacitinib: A multicenter retrospective study.
J Am Acad Dermatol;
90(5): 1031-1034, 2024 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38199282
7.
Survival, efficacy and safety of tralokinumab after 32 and 52 weeks of treatment for moderate-to-severe atopic dermatitis in adults: A multicentre real-world study.
J Eur Acad Dermatol Venereol;
38(1): e11-e13, 2024 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37483150
8.
Beneficial effects of upadacitinib on alopecia areata associated with atopic dermatitis: A multicenter retrospective study.
J Am Acad Dermatol;
89(6): 1251-1253, 2023 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37169293
9.
Long-term drug survival of dupilumab and associated predictors in moderate-to-severe atopic dermatitis: A real-world prospective cohort study.
J Eur Acad Dermatol Venereol;
37(6): e757-e759, 2023 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36662631
10.
A 52-week update of a multicentre Italian real-world experience on effectiveness and safety of dupilumab in adolescents with moderate-to-severe atopic dermatitis.
J Eur Acad Dermatol Venereol;
37(3): e384-e388, 2023 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36225088
11.
Management of adult patients with severe atopic dermatitis treated with dupilumab during COVID-19 pandemic: A single-center real-life experience.
Dermatol Ther;
33(4): e13765, 2020 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32500660
12.
UVA1 phototherapy as a treatment option for plaque psoriasis in HIV-positive patients.
Photodermatol Photoimmunol Photomed;
36(6): 478-480, 2020 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32473061
13.
A Multidisciplinary Approach Is Beneficial in Atopic Dermatitis.
Dermatol Ther (Heidelb);
2024 May 30.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38811470
14.
Drug Survival of Upadacitinib and Predicting Factors of Discontinuation in Adult Patients Affected by Moderate-to-Severe Atopic Dermatitis: An Italian Multicenter Analysis.
J Clin Med;
13(2)2024 Jan 18.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38256686
15.
AtopyReg®, the Prospective Italian Patient Registry for Moderate-to-Severe Atopic Dermatitis in Adults: Baseline Demographics, Disease Characteristics, Comorbidities, and Treatment History.
Am J Clin Dermatol;
25(1): 149-160, 2024 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37725229
16.
Italian S3-Guideline on the treatment of Atopic Eczema - Part 1: Systemic therapy, adapted from EuroGuiDerm by the Italian Society of Dermatology and STD (SIDEMAST), the Italian Association of Hospital Dermatologists (ADOI) and the Italian Society of Allergological and Environmental Dermatology (SIDAPA).
Ital J Dermatol Venerol;
159(3): 223-250, 2024 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38727633
17.
Italian S3-Guideline on the treatment of Atopic Eczema - First Update, adapted from EuroGuiDerm by the Italian Society of Dermatology and STD (SIDEMAST), the Italian Association of Hospital Dermatologists (ADOI) and the Italian Society of Allergological and Occupational Dermatology (SIDAPA).
Ital J Dermatol Venerol;
159(3): 279-284, 2024 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38727635
18.
Italian S3-Guideline on the treatment of Atopic Eczema - Part 2: non-systemic treatments and treatment recommendations for special AE patient populations, adapted from EuroGuiDerm by the Italian Society of Dermatology and STD (SIDEMAST), the Italian Association of Hospital Dermatologists (ADOI) and the Italian Society of Allergological and Occupational Dermatology (SIDAPA).
Ital J Dermatol Venerol;
159(3): 251-278, 2024 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38727634
19.
The realistic positioning of UVA1 phototherapy after 25 years of clinical experience and the availability of new biologics and small molecules: a retrospective clinical study.
Front Med (Lausanne);
10: 1295145, 2023.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38076241
20.
Definition of the Clinical Characteristics of Patients with Moderate and Severe Atopic Dermatitis for Whom Narrow-Band UVB (NB-UVB) and Medium-Dose UVA1 Phototherapies Are Still Valuable Treatment Options at the Age of Biologics.
J Clin Med;
12(9)2023 May 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37176743